Gene News and Research

Latest Gene News and Research

Study identifies more than 200 new genes linked to depression

More than 200 genes linked to depression have been newly identified in a worldwide study led by UCL researchers.

10 Jan 2024

Unearthing individual-level mutation risk patterns

Mutations, which occur continuously in every cell of our bodies, are a key contributor to cancer, ageing, and neurodegeneration.

10 Jan 2024

Research discovers fibronectin's role in BRAF-mutant thyroid cancer resistance

New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, PhD, could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene - a mutation also responsible for some types of melanoma, colorectal cancer, leukemia, lymphoma, and ovarian cancer.

10 Jan 2024

New algorithm proves to be a powerful tool for detection and identification of novel bacterial organisms

Researchers developed the NOVA algorithm to systematically analyze bacterial isolates unidentified using traditional methods such as matrix-assisted laser desorption ionization-time of flight mass spectrometry and partial 16S rRNA gene sequencing using whole genome sequencing.

10 Jan 2024

Landmark study confirms five key Parkinson's Disease variants in largest meta-analysis

Rare Parkinson’s disease (PD) variants in a large-scale cohort.

10 Jan 2024

"TimeMachine" algorithm revolutionizes circadian rhythm analysis with single blood sample

"TimeMachine," an algorithm developed by U.S. researchers, accurately predicts circadian phase from a single blood sample using gene expression, offering a novel, efficient approach to understanding circadian rhythms and their impact on health.

9 Jan 2024

New approach to Parkinson's treatment focuses on stopping toxic protein production

Like the Greek mythological beast with a snake's tail and two ferocious heads, a potential Parkinson's medicine created in the lab of chemist Matthew Disney, Ph.D., is also a type of chimera bearing two heads.

9 Jan 2024

Breakthrough in gene editing: Enhanced virus-like particles promise new era in genetic disease treatment

Researchers developed an advanced prime editor-engineered virus-like particle (PE-eVLP) system, significantly enhancing gene editing efficiency in human cells and showing potential for treating genetic diseases.

9 Jan 2024

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Children and adults with rare, deadly genetic diseases have fresh hope for curative therapies, thanks to a new collaboration between the Innovative Genomics Institute (IGI) and Danaher Corporation, a global life sciences and diagnostics innovator.

9 Jan 2024

Marking a vital milestone for Vertex and Charles River

Charles River’s Memphis facility approved to manufacture Vertex’s CASGEVY™ therapy, the world’s first gene-edited therapy targeting severe sickle cell disease

From Charles River 9 Jan 2024

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Renowned experts from across the CGT and robotics industries, Professor John Campbell, Dr Matthew Li, Dr Paul Roberts, and Geoffrey Hodge appointed to provide strategic and technical perspectives.

From Cellular Origins 9 Jan 2024

Largest genetic study of gestational diabetes discovers nine novel genetic regions linked to severe and common pregnancy complication

Researchers investigated the genetic underpinnings of Gestational Diabetes Mellitus (GDM) and its relationship with Type 2 Diabetes (T2D) through a genome-wide association study ((GWAS), identifying distinct and shared genetic factors.

9 Jan 2024

Gene News and Research

Latest Gene News and Research

Study identifies more than 200 new genes linked to depression

Unearthing individual-level mutation risk patterns

Research discovers fibronectin's role in BRAF-mutant thyroid cancer resistance

New algorithm proves to be a powerful tool for detection and identification of novel bacterial organisms

Landmark study confirms five key Parkinson's Disease variants in largest meta-analysis

"TimeMachine" algorithm revolutionizes circadian rhythm analysis with single blood sample

New approach to Parkinson's treatment focuses on stopping toxic protein production

Breakthrough in gene editing: Enhanced virus-like particles promise new era in genetic disease treatment

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Marking a vital milestone for Vertex and Charles River

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Largest genetic study of gestational diabetes discovers nine novel genetic regions linked to severe and common pregnancy complication

Infammasomes provide a therapeutic target against human diseases

Itchy skin? Possible atopic dermatitis? Lavender essential oil might be just what you're looking for

Research potentially expands options for patients with aggressive childhood cancer

£30M clinical study will enhance the understanding of NASH cirrhosis

3D mini-organs from human fetal brain tissue unlock new frontier in brain research

Scientists unveil the hidden respiratory mechanisms of gut bacteria

Three cytokine pairs found to be responsible for the body's damaging response to sepsis

UCSF research lays the groundwork for preventing deafness

Industry focus eBook - Cell and gene therapy (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production